# A Trial Involving Treatment of BB2603 in Subjects With Distal Subungual Onychomycosis of the Toenail

> **NCT04188574** · PHASE2 · COMPLETED · sponsor: **Blueberry Therapeutics** · enrollment: 111 (actual)

## Conditions studied

- Distal Subungual Onychomycosis
- Fungal Infection
- Fungus, Nail

## Interventions

- **DRUG:** BB2603-1
- **DRUG:** BB2603-3
- **DRUG:** BB2603-10
- **OTHER:** Vehicle

## Key facts

- **NCT ID:** NCT04188574
- **Lead sponsor:** Blueberry Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-22
- **Primary completion:** 2022-12-06
- **Final completion:** 2023-06-28
- **Target enrollment:** 111 (ACTUAL)
- **Last updated:** 2023-08-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04188574

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04188574, "A Trial Involving Treatment of BB2603 in Subjects With Distal Subungual Onychomycosis of the Toenail". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04188574. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
